Literature DB >> 19290496

Bioreactor technology in cardiovascular tissue engineering.

H Mertsching1, J Hansmann.   

Abstract

Cardiovascular tissue engineering is a fast evolving field of biomedical science and technology to manufacture viable blood vessels, heart valves, myocardial substitutes and vascularised complex tissues. In consideration of the specific role of the haemodynamics of human circulation, bioreactors are a fundamental of this field. The development of perfusion bioreactor technology is a consequence of successes in extracorporeal circulation techniques, to provide an in vitro environment mimicking in vivo conditions. The bioreactor system should enable an automatic hydrodynamic regime control. Furthermore, the systematic studies regarding the cellular responses to various mechanical and biochemical cues guarantee the viability, bio-monitoring, testing, storage and transportation of the growing tissue.The basic principles of a bioreactor used for cardiovascular tissue engineering are summarised in this chapter.

Entities:  

Mesh:

Year:  2009        PMID: 19290496     DOI: 10.1007/978-3-540-69357-4_2

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  2 in total

1.  Upcyte® microvascular endothelial cells repopulate decellularized scaffold.

Authors:  Katharina Scheller; Iris Dally; Nadja Hartmann; Bernhard Münst; Joris Braspenning; Heike Walles
Journal:  Tissue Eng Part C Methods       Date:  2012-09-13       Impact factor: 3.056

2.  Bacterial Nanocellulose-Based Grafts for Cell Colonization Studies: An In Vitro Bioreactor Perfusion Model.

Authors:  Max Wacker; Jan Riedel; Priya Veluswamy; Maximilian Scherner; Jens Wippermann; Heike Walles; Jörn Hülsmann
Journal:  Methods Mol Biol       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.